UTMD
Analyst Coverage

No analyst coverage available for this stock.

PRICE
Prev Close
63.34
Open
63.43
Day Range62.64 – 65.18
62.64
65.18
52W Range52.00 – 71.81
52.00
71.81
61% of range
VOLUME & SIZE
Avg Volume
14.0K
FUNDAMENTALS
P/E Ratio
18.9x
EPS (TTM)
Div Yield
0.01%
Beta
0.53
Low vol
TECHNICAL
RSI (14)
61
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 94 days
Aug 20
Key MetricsTTM
Market Cap$203.78M
Revenue TTM$37.53M
Net Income TTM$10.85M
Free Cash Flow$13.02M
Gross Margin53.6%
Operating Margin28.8%
Net Margin28.9%
Return on Equity9.1%
Return on Assets8.7%
Debt / Equity0.00
Current Ratio28.64
EPS TTM$3.41

UTMD News

About

utah medical products, inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in hundreds of countries around the world as the standard for obtaining optimal long term outcomes for their patients. for more information about utah medical products, inc., visit utmd’s website at www.utahmed.com.

CEO
Kevin Cornwell
Marcena H. ClawsonVice President of Corporate Sales
Mark L. FoxVice President of Marketing
Brian L. KoopmanPrincipal Financial Officer, Accounting Manager & Controller
Kevin L. CornwellChairman, Chief Executive Officer, President & Secretary